A recent prospective investigation in a large cohort of patients with CKD stages have identified elevated serum levels of interleukin-6, C-reactive protein, and FGF23 as independent risk factors for mortality in CKD (Munoz Mendoza et al., 2017). This evidence concerns the gene IL6 and chronic kidney disease.